from october 1973 to october 1977 the ecog prospectively evaluated cyclophosphamide , methotrexate , and fluorouracil ( cmf ) versus cmf plus fluoxymesterone ( cmfh ) maintenance therapies in responders to 6 months of induction therapy which consisted of either cmf , cmf plus prednisone ( cmfp ) , or adriamycin plus vincristine ( av ) .
C0280279
cmfh
C0010583
cmf